GB201802264D0 - Cancer treatments - Google Patents

Cancer treatments

Info

Publication number
GB201802264D0
GB201802264D0 GBGB1802264.0A GB201802264A GB201802264D0 GB 201802264 D0 GB201802264 D0 GB 201802264D0 GB 201802264 A GB201802264 A GB 201802264A GB 201802264 D0 GB201802264 D0 GB 201802264D0
Authority
GB
United Kingdom
Prior art keywords
cancer treatments
treatments
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1802264.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cinda Pharma AB
Original Assignee
Cinda Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cinda Pharma AB filed Critical Cinda Pharma AB
Priority to GBGB1802264.0A priority Critical patent/GB201802264D0/en
Publication of GB201802264D0 publication Critical patent/GB201802264D0/en
Priority to US16/969,165 priority patent/US20210038577A1/en
Priority to CN201980019617.9A priority patent/CN111867587A/en
Priority to RU2020126540A priority patent/RU2020126540A/en
Priority to JP2020565544A priority patent/JP2021513573A/en
Priority to AU2019219322A priority patent/AU2019219322A1/en
Priority to CA3091085A priority patent/CA3091085A1/en
Priority to BR112020016265-5A priority patent/BR112020016265A2/en
Priority to SG11202007535VA priority patent/SG11202007535VA/en
Priority to PCT/EP2019/053444 priority patent/WO2019155086A1/en
Priority to EP19704619.6A priority patent/EP3752151A1/en
Priority to MA051821A priority patent/MA51821A/en
Priority to IL276668A priority patent/IL276668A/en
Ceased legal-status Critical Current

Links

GBGB1802264.0A 2018-02-12 2018-02-12 Cancer treatments Ceased GB201802264D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1802264.0A GB201802264D0 (en) 2018-02-12 2018-02-12 Cancer treatments
MA051821A MA51821A (en) 2018-02-12 2019-02-12 THIOREDOXIN REDUCTASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER
CA3091085A CA3091085A1 (en) 2018-02-12 2019-02-12 Thioredoxin reductase inhibitors for use in the treatment of cancer
CN201980019617.9A CN111867587A (en) 2018-02-12 2019-02-12 Thioredoxin reductase inhibitors for the treatment of cancer
RU2020126540A RU2020126540A (en) 2018-02-12 2019-02-12 Thioredoxin reductase inhibitors for use in cancer treatment
JP2020565544A JP2021513573A (en) 2018-02-12 2019-02-12 Thioredoxin reductase inhibitor used to treat cancer
AU2019219322A AU2019219322A1 (en) 2018-02-12 2019-02-12 Thioredoxin reductase inhibitors for use in the treatment of cancer
US16/969,165 US20210038577A1 (en) 2018-02-12 2019-02-12 Thioredoxin reductase inhibitors for use in the treatment of cancer
BR112020016265-5A BR112020016265A2 (en) 2018-02-12 2019-02-12 THYOREDOXIN REDUCTASE INHIBITORS FOR USE IN CANCER TREATMENT
SG11202007535VA SG11202007535VA (en) 2018-02-12 2019-02-12 Thioredoxin reductase inhibitors for use in the treatment of cancer
PCT/EP2019/053444 WO2019155086A1 (en) 2018-02-12 2019-02-12 Thioredoxin reductase inhibitors for use in the treatment of cancer
EP19704619.6A EP3752151A1 (en) 2018-02-12 2019-02-12 Thioredoxin reductase inhibitors for use in the treatment of cancer
IL276668A IL276668A (en) 2018-02-12 2020-08-12 Thioredoxin reductase inhibitors for use in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1802264.0A GB201802264D0 (en) 2018-02-12 2018-02-12 Cancer treatments

Publications (1)

Publication Number Publication Date
GB201802264D0 true GB201802264D0 (en) 2018-03-28

Family

ID=61731277

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1802264.0A Ceased GB201802264D0 (en) 2018-02-12 2018-02-12 Cancer treatments

Country Status (1)

Country Link
GB (1) GB201802264D0 (en)

Similar Documents

Publication Publication Date Title
IL271946A (en) Combination cancer therapy
IL263123A (en) Cancer treatments
GB201903546D0 (en) Cancer treatment
ZA202005847B (en) Cancer therapy
PT3576740T (en) Cancer treatment
GB201706451D0 (en) Cancer treatment
GB201820660D0 (en) Cancer treatments
IL268463A (en) Cancer treatment
IL282093A (en) Combination therapy for cancer
IL287652A (en) Cancer treatment
GB201808564D0 (en) Treatments
IL285466A (en) Cancer treatment
GB201814487D0 (en) Cancer
GB201800733D0 (en) Cancer
ZA202006321B (en) Treatments
GB201707864D0 (en) Platinum-reistant cancer treatment
IL274626A (en) Cancer treatment
EP3576791A4 (en) Calreticulin-mediated cancer treatment
IL288035A (en) Cancer treatment
GB201704909D0 (en) Cancer therapy
GB201819920D0 (en) Cancer treatment
GB201711855D0 (en) Cancer therapy
GB201807415D0 (en) Cancer treatments
GB201802264D0 (en) Cancer treatments
GB201720533D0 (en) Cancer treatments

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)